Multi-criteria decision analysis for setting priorities on HIV/AIDS interventions in Thailand by Youngkong, Sitaporn et al.
RESEARCH Open Access
Multi-criteria decision analysis for setting




1 and Rob Baltussen
2
Abstract
Background: A wide range of preventive, treatment, and care programs for HIV/AIDS are currently available and
some of them have been implemented in Thailand. Policy makers are now facing challenges on how the scarce
resources for HIV/AIDS control can be spent more wisely. Although effectiveness and cost-effectiveness information
is useful for guiding policy decisions, empirical evidence indicates the importance of other criteria, such as equity
and the characteristics of the target population, also play important roles in priority setting. This study aims to
experiment with the use of multi-criteria decision analysis (MCDA) to prioritise interventions in HIV/AIDS control in
Thailand.
Methods: We used MCDA to rank 40 HIV/AIDS interventions on the basis of the priority setting criteria put forward
by three groups of stakeholders including policy makers, people living with HIV/AIDs (PLWHA), and village health
volunteers (VHVs). MCDA incorporated an explicit component of deliberation to let stakeholders reflect on the rank
ordering, and adapt where necessary.
Results: Upon deliberation, policy makers expressed a preference for programs that target high risk groups such as
men who have sex with men, injecting drug users, and female sex workers. The VHVs preferred interventions that
target the youth or the general population, and gave lower priority to programs that target high risk groups.
PLWHA gave all interventions the same priority. The rank order correlation between the priorities as expressed
before and after deliberation was 37% among the policy makers and 46% among the VHVs.
Conclusion: This study documented the feasibility of MCDA to prioritize HIV/AIDS interventions in Thailand, and
has shown the usefulness of a deliberative process as an integrated component of MCDA. MCDA holds potential
to contribute to a more transparent and accountable priority setting process, and further application of this
approach in the prioritisation of health interventions is warranted.
Keywords: Multi-criteria decision analysis, Priority setting, HIV/AIDS interventions, Discrete choice experiment
Background
Since HIV/AIDS has long been recognized as a leading
cause of death and a high burden of disease in Thailand
[1-3], a wide range of preventive, treatment, and care
programs have been implemented to combat the disease.
Recently, it was suggested that funding decisions on
these programs are not taken in a systematic manner
and that the resulting mix of interventions is not offer-
ing the best value for money [4]. Consequently, Thai
policy makers now face the challenge of how the scarce
resources available for HIV/AIDS control can be spent
more wisely.
A range of studies are available to guide Thai policy
makers to prioritise HIV/AIDS interventions. Interna-
tional estimates are available on the effectiveness and
cost-effectiveness of HIV/AIDS interventions [5-7], and a
recent document has systematically reviewed this infor-
mation - in combination with national estimates - to pro-
vide informed priorities for HIV/AIDS control [4]. Yet
the analysis falls short of including other criteria that
may also play important roles in effective decision-mak-
ing, such as ethical and social concerns. For example, the
preference of society to pursue not only efficiency goals
(that could result in prevention-oriented strategies for
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for example, result in treatment-oriented strategies for
the severely ill) may have a large impact on the choice of
programs [8-10]. This indicates the need for multiple cri-
teria decision analysis (MCDA) to account for other cri-
teria beyond effectiveness and cost-effectiveness in the
decision-making process [11-14].
Although MCDA is used in only a few applications to
guide the making of resource allocation decisions on
health, it is routinely used in environmental, agricultural
and marketing sciences to set intervention priorities [14].
In those disciplines, MCDA has evolved as a response to
the observed inability of people to effectively analyze mul-
tiple streams of dissimilar information. The analysis estab-
lishes preferences between interventions by reference to
an explicit set of criteria that the decision-making body
has identified. A key component of every MCDA is the
performance matrix that describes the performance of the
interventions against each criterion. The performance
matrix may be the final product of the analysis, allowing
the decision makers to qualitatively rank the interventions.
Such intuitive processing of the data can be quick and
effective, but it may also lead to the use of unjustified
assumptions, causing an incorrect ranking of options. In
analytically more sophisticated MCDA techniques, the
information in the basic matrix is usually converted into
consistent numerical values. The key idea is to construct
scales representing preferences for the consequences, to
weigh the scales for their relative importance, and then to
calculate weighted averages across the preference scales
[14]. In recent applications of MCDA [15-19], it has been
criticized for its quantitative nature - studies typically rank
ordered interventions on the basis of weighted averages
and, in this way, consider quantifiable criteria only. To
date, some attempts to capture non-quantifiable criteria to
support the deliberative process have been reported
[20,21]. This confirms that MCDA should rather include a
deliberative process or other qualitative tools to also con-
sider non-quantifiable concerns [20,22-25] and foster well-
balanced judgments on intervention priorities [26,27].
The primary aim of this study is to experiment with
the use of MCDA, including the use of a deliberative
process to prioritise interventions in HIV/AIDS control
in Thailand. This research follows up on a recent study
that employed discrete choice experiments (DCE) to
identify and measure the relative importance of various
quantifiable and non-quantifiable criteria for the priority
setting of HIV/AIDS interventions in Thailand among
various stakeholders [28].
Methods
The MCDA in the present study includes three compo-
nents. Firstly, we assessed the performance of interven-
tions on the criteria as identified in the DCE (i.e. we
constructed the performance matrix). Second, we ranked
ordered interventions. Third, we engaged with the var-
ious stakeholders in a deliberative process to adapt the
rank ordering where necessary. We also compared the
rank order of interventions before and after the delib-
erative process. These components are discussed in turn.
Constructing the performance matrix
As a starting point, we identified a broad set of 40 HIV/
AIDS interventions that are already implemented, or eli-
gible for implementation, in Thailand. We then con-
structed the performance matrix, i.e. we scored each of
the selected HIV/AIDS interventions as a function of
their performance on a set of criteria as identified in a
recent DCE study [28]. This study identified the criteria
to be relevant to the priority setting of HIV/AIDS con-
trol in Thailand through group discussions with each
group of stakeholders including policy makers, people
living with HIV/AIDS (PLWHA), and community mem-
bers represented by village health volunteers (VHVs).
The resulting criteria from the three group discussions
were compared and finally those that were identified by
two or more discussion groups were selected. These
included: target groups of interventions (i.e. children,
teenagers, adults, and high-risk adults); gender of target
groups (i.e. female versus male); type of interventions
(i.e. prevention, treatment of patients with HIV, and
treatment of patients with AIDS); effectiveness (i.e. low
versus high effectiveness); and quality of evidence (i.e.
weak versus strong evidence). In the performance
matrix, ‘0’ denotes the absence of and ‘1’ indicates the
presence of a criterion level (see Additional file 1:
Appendix 1). Information on target group, gender of
target group and type of intervention was identified
from each intervention itself, whereas the information
on effectiveness of intervention and quality of evidence
on effectiveness were based on the review conducted by
Pattanaphesaj and Teerawattananon [4].
Rank ordering of interventions
Subsequently, we estimated the probability of selection
of an intervention by using the logistic regression model
derived from the DCE study [28]:
Logit(P) = ln [P/(1-P)] = b0 + b1-3 Target group + b4-5
Gender of target group + b6-7 Type of intervention + b8
Effectiveness + b9 Quality of evidence on effectiveness + ε
where P is the probability of an intervention being
selected by the respondents, b0 is the constant term, bi
(i = 1-9) are the coefficients of the model indicating the
probability of selection relative to the reference criterion
level, and ε is the unobservable error term. The regres-
sion coefficients for all criteria were obtained from each
of the three groups of stakeholders - policy makers,
PLWHA, and community members - represented by
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tional file 1: Appendix 2). Next, all interventions were
ranked in order of their probability of selection.
Deliberative process
In the deliberative process, group discussions were inde-
pendently organized between July and August 2009 with
three groups of stakeholders: six policy makers at the
national level who are heavily involved in health resource
allocation decisions in Thailand specifically on HIV/
AIDS (’policy makers’); six members of the Thai network
for PLWHA, representing PLWHA groups at the regio-
nal level in Thailand (’PLWHA’); and six community
members who have been trained by public health provi-
ders to be the VHVs in Samutprakan province (‘VHVs’).
Participants were selected purposively from each group
of stakeholders on the basis of their participation in the
previous DCE study to ensure that they were familiar
with the DCE and the priority setting process. Each
group discussion began with a brief introduction of the
purpose of the meeting. Next, participants were pre-
sented with the rank ordering of the interventions, and
they were then asked whether they agreed with the rank
and to provide their justifications. We then asked them
to re-classify all interventions into three categories -
based on the traffic-light analogy: ‘good candidates for
implementation’ (green), ‘not good candidates for imple-
mentation’ (red), and ‘in-between’ (yellow). This re-classi-
fication was done through consensus or, when necessary,
through voting. In all steps, participants were encouraged
by the researcher (SY) to discuss, bring in additional cri-
teria, and share their opinions with justifications regard-
ing their preferences.
Comparison of rankings
We compared the rank ordering of interventions before
and after the deliberative process to explore the impact
of deliberation by estimating the Spearman’s rank corre-
lation coefficient.
Research ethics
This study was approved by the Institute for the Devel-
opment of Human Research Protections, Ministry of
Public Health, Thailand. All participants provided their
written informed consent.
Results
The rank ordering of the 40 HIV/AIDS interventions
before and upon deliberation is presented in Table 1. As
indicated by the ranking results before deliberation, the
group of policy makers expressed a preference for pre-
ventive programs that are highly effective and target high
risk groups such as men who have sex with men (MSM),
injecting drug users (IDU), female sex workers (FSW),
and HIV sero-discordant couples, with good quality of
evidence on intervention effectiveness. The five interven-
tions with the highest priority were voluntary counseling
and testing (VCT) for IDU, street outreach for IDU, sub-
stitution treatment for IDU, improved sexual transmitted
infection (STI) treatment services for IDU, and improved
STI treatment services for HIV sero-discordant couples.
Upon deliberation, the group of policy makers rein-
forced their preference for highly effective programs that
target high risk groups. Community-based education and
programs that target the youth or the general population
(with the exception for those aimed at the improvement
of STI treatment services) were not preferred. In the
deliberative process, a number of additional criteria were
put forward in addition to those identified in the DCE.
The policy maker group proposed cost-effectiveness as
an important additional criterion. This group also added
the criteria of whether an intervention could be used for
multiple purposes, and of safety. For example, a policy
maker argued that introducing nucleic acid test screening
for blood testing enables the Thai Red Cross Society to
simultaneously investigate the existence of Hepatitis B
and C with detecting HIV in the same specimen, thus
creating added value. Also, a reliable blood donation sys-
tem is very important to secure safety in Thailand in this
respect. The other criterion mentioned was the impor-
tance of targeting health care workers at risk as a way of
encouraging them to work with PLWHA in hospitals.
This led to a change from the rank 10
th of the post-expo-
sure prophylaxis for healthcare workers before delibera-
tion to ‘good candidate for implementation’ category,
upon deliberation.
The group of PLWHA expressed a strong preference
for the treatment or care for AIDS patients i.e. highly
active antiretroviral therapy, and treatment for opportu-
nistic infection and other palliative care, as elicited by
the DCE study (Table 1). However, upon deliberation,
PLWHA gave almost all of the 40 interventions the
same priority. They argued that every intervention was
important and should be implemented together to pre-
vent HIV infection. This group of PLWHA also asked
that more budget possibilities be found from several
sources of funding in order to secure the programs and
that otherwise, HIV/AIDS programs should be smaller
in scope so policy makers can cover all programs within
their limited budgets.
PLWHA suggested the availability of alternatives as an
additional criterion. For example, improving STI treat-
ment services was not seen as a priority as alternative ser-
vices were available in hospitals. PLWHA strongly
disagreed with considering cost-effectiveness as a criterion
- they argued that if an intervention is effective, it should
be implemented, and that financial considerations should
not be important. PLWHA also prioritized interventions
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HIV/AIDS intervention (target group) Ranking*






















Community based education (MSM) 98.82 (94.9-
99.7)
11 3 64.34 (45.2-
79.8)
15 1 71.28 (48.9-
86.6)
15 3
Community based education (IDU) 96.73 (86.1-
99.3)
14 3 79.67 (63.1-
90.0)
11 1 78.31 (56.8-
90.8)
13 3
Community based education (Youth) 99.86 (98.8-
100)
2 3 92.14 (79.0-
97.3)
2 1 96.56 (87.6-
99.1)
11
Community based education (FSW) 99.79 (97.8-
100)
4 3 78.57 (51.9-
92.6)
12 1 90.81 (69.1-
97.8)
53




8 1 71.97 (47.4-
88.0)
14 1 87.45 (66.1-
96.1)
92
Workplace based education ± condom distribution/free
STI clinic (general public)
98.58 (92.4-
99.7)
12 3 84.45 (67.7-
93.4)
9 1 87.06 (67.8-
95.5)
10 2
Workplace based education ± condom distribution/free
STI clinic (male conscripts in military camps)
99.84 (99.0-
100)
3 2 77.15 (56.5-
90.0)
13 1 89.03 (71.7-
96.3)
82
School-based sex education programmes (+ life skills) 99.49 (96.8-
99.9)
7 1 89.15 (75.8-
95.6)
4 1 95.19 (86.0-
98.4)
21
Peer education (MSM) 98.82 (94.9-
99.7)
11 1 64.34 (45.2-
79.8)
15 1 71.28 (48.9-
86.6)
15 2
Peer education (IDU) 99.10 (94.3-
99.9)
9 1 84.84 (67.2-
93.9)
8 1 83.66 (60.2-
94.5)
11 3
Peer education (Youth) 99.00 (93.9-
99.8)
10 3 86.24 (70.5-
94.3)
7 1 89.56 (72.8-
96.5)
71
Peer education (FSW) 99.79 (97.8-
100)
4 1 78.57 (51.9-
92.6)
12 1 90.81 (69.1-
97.8)
53
Mass media campaign (general public) 98.58 (92.4-
99.7)
12 3 84.45 (67.7-
93.4)
9 1 87.06 (67.8-
95.5)
10 1
VCT ± STI clinic/Condom distribution (Prison inmate) 99.54 (97.0-
99.9)
6 1 88.01 (72.9-
95.2)
6 1 92.19 (77.7-
97.6)
42
VCT ± STI clinic/Condom distribution (MSM) 99.84 (99.0-
100)
3 1 77.15 (56.5-
89.8)
13 1 89.03 (71.7-
96.3)
83
VCT ± STI clinic/Condom distribution (IDU) 99.87 (98.8-
100)
1 1 91.29 (76.4-
97.1)
3 1 94.36 (80.0-
98.6)
31




6 1 88.01 (72.9-
95.2)
6 1 92.19 (77.7-
97.6)
42
VCT ± STI clinic/Condom distribution (Youth) 99.49 (96.8-
99.9)
7 2 89.15 (75.8-
95.6)
4 1 95.19 (86.0-
98.4)
21
VCT ± STI clinic/Condom distribution (FSW) 99.22 (94.4-
99.9)
8 1 71.97 (47.3-
88.0)
14 1 87.45 (66.1-
96.1)
93
VCT ± STI clinic/Condom distribution (general public) 99.61 (97.0-
100)
5 2 88.57 (71.5-
96.0)


















































































































8Table 1 The HIV/AIDS interventions?’? ranking based on DCE, and the ranking after group discussions (Continued)
Routine (provider-initiated) voluntary HIV screening at
healthcare settings (general public)
99.61 (97.0-
100)
5 2 88.57 (71.5-
96.0)
5 1 90.51 (70.7-
97.4)
61
Condom use (availability and accessibility) (FSW) 99.79 (97.8-
100)
4 1 78.57 (51.9-
92.6)
12 1 90.81 (69.1-
97.8)
52




12 3 84.45 (67.7-
93.4)
9 1 87.06 (67.8-
95.5)
10 1




6 1 88.01 (72.9-
95.2)
6 1 92.19 (77.7-
97.6)
41
Condom use (availability and accessibility) (MSM) 99.84 (99.0-
100)
3 1 77.15 (56.5-
89.8)
13 1 89.03 (71.7-
96.3)
82
Street outreach (IDU) 99.87 (98.8-
100)
1 1 91.29 (76.4-
97.1)
3 1 94.36 (80.0-
98.6)
31
Substitution treatment (IDU) 99.87 (98.8-
100)
1 1 91.29 (76.4-
97.1)
3 1 94.36 (80.0-
98.6)
33
Using nucleic acid test screening (NAT) of voluntary
blood donations (general public)
98.58 (92.4-
99.7)
12 1 84.45 (67.7-
93.4)
9 2 87.06 (67.8-
95.5)
10 3




12 1 84.45 (67.7-
93.4)
9 1 87.06 (67.8-
95.5)
10 2
Improved STI treatment services (MSM) 99.84 (99.0-
100)
3 1 77.15 (56.5-
89.8)
13 2 89.03 (71.7-
96.3)
82
Improved STI treatment services (IDU) 99.87 (98.8-
100)
1 1 91.29 (76.4-
97.1)
3 2 94.36 (80.0-
98.6)
31




1 1 91.29 (76.4-
97.1)
3 2 94.36 (80.0-
98.6)
32
Improved STI treatment services (Youth) 99.86 (98.8-
100)
2 1 92.14 (79.0-
97.3)
2 2 96.56 (87.6-
99.1)
11
Improved STI treatment services (FSW) 99.79 (97.8-
100)
4 1 78.57 (51.9-
92.6)
12 2 90.81 (69.1-
97.8)
52
Improved STI treatment services (general public) 99.61 (97.0-
100)
5 1 88.57 (71.5-
96.0)
5 2 90.51 (70.7-
97.4)
62
Prevention mother to child transmission 99.79 (97.8-
100)
4 1 78.57 (51.9-
92.6)
12 1 90.81 (69.1-
97.8)
52
PEP for healthcare workers 97.25 (86.1-
99.5)
13 1 80.55 (61.5-
91.5)
10 1 74.46 (47.8-
90.3)
14 3
Increase alcohol tax 98.58 (92.4-
99.7)
12 3 84.45 (67.7-
93.4)
9 3 87.06 (67.8-
95.5)
10 3
Highly active antiretroviral therapy for HIV/AIDS 95.64 (89.0-
99.8)
15 1 94.92 (89.0-
98.7)
1 1 82.24 (55.4-
94.5)
12 2
Definitive treatment and care for opportunistic infections,
and other palliative care
95.64 (89.0-
99.8)
15 1 94.92 (89.0-
98.7)
1 1 82.24 (55.4-
94.5)
12 2
DCE, discrete choice experiment; PLWHA, people living with HIV/AIDS; VHVs, village health volunteers; MSM, men who have sex with men; IDU, injectable drug users; FSW, female sex workers; STI, sexual transmitted
infection; VCT, voluntary counseling and testing; PEP, post-exposure prophylaxis
*Rank 1 is for the interventions in a group of the highest probability of selection comparing to others on the list
†The rankings from DCE depend on each group of stakeholders that unable to compare cross the groups
‡The rankings from group discussion of each group of stakeholders categorized into three groups through consensus; rank 1 is the intervention that was probable ‘good candidate for implementation’; rank 2 is the
















































































































8that target the general population rather than high risk
groups, because interventions for the general population
cover a larger segment of the population, and reflect their
notion that everyone has equal risk of HIV infection. One
participant argued: “If these (interventions) are the
national policy, they should be implemented to everyone
not only the high risk groups. This is because everyone is
at equal risk of HIV infection. We are all the same”.
The preferences of VHVs cohered largely with those
of policy makers except for the target group of the
interventions: VHVs preferred interventions that target
the youth rather than high risk populations. Conse-
quently, community-based education and improvement
of STI treatment services for the youth were the highest
priority (Table 1). This preference was also confirmed
upon deliberation. VHVs introduced the number of ben-
eficiaries as an additional criterion. One volunteer men-
tioned: “Mass media campaigns have an impact on lots
of people in society. So we think this intervention is
beneficial for society at large”. Furthermore, VHVs
emphasized the need to adapt certain interventions to
suit the groups targeted.
There was a significant correlation between the rank
ordering before and after deliberation for policy makers
(correlation coefficient 37%) and VHVs (46%). The cor-
relation coefficient presents the consistency of results
between the DCE ranking and deliberation ranking. No
such significant correlation was found for the PLWHA.
In addition, from the group discussions, we found that
both policy makers and VHVs were generally positive
about the ease of interpreting DCE results and the
MCDA process, whereas PLWHA were generally nega-
tive because of the difficulty of the DCE questionnaire,
which might lead to a misunderstanding of the exercise
among the respondents.
Discussion
This study has experimented with the use of MCDA to
guide the priority setting of HIV/AIDS interventions in
Thailand, on the basis of consultations with the relevant
stakeholders through a deliberative process.
This study revealed the importance of five criteria
included in the DCE (i.e. target groups of interventions,
gender of target groups, type of interventions, effective-
ness, and quality of evidence on effectiveness), and a num-
ber of additional criteria raised during the deliberative
process (i.e. ethical and social concerns, cost-effectiveness,
(non)availability of alternatives; number of beneficiaries;
and inappropriate use or abuse of interventions). This
reflects that stakeholders consider multiple criteria in
prioritising interventions.
The abovementioned results highlight that MCDA has
good potential to be used for the making of explicit
prioritisation decisions. Also, we observed that the group
of policy makers and VHVs - although not PLWHA
respondents - applauded the systematic approach for
priority setting, including the development of relevant
criteria, the presentation of the performance of interven-
tions against these criteria, and the deliberative process.
Although MCDA seems difficult for PLWHA as they
may not be familiar or comfortable to make trade-off
decisions, the considerable overlap of the rank ordering
b e f o r ea n du p o nd e l i b e r a t i o ni nt h eg r o u po fp o l i c y
makers and VHVs indicates that the quantifiable criteria
used in the DCE partly reflect the concerns that stake-
holders have in their intervention priorities. We believe
that, through its explicit approach, MCDA contributes to
the transparency and accountability of the priority setting
process. Moreover, the provision of the DCE ranking
reduces the stream of information that stakeholders need
to absorb when prioritising many interventions simulta-
neously. We therefore advocate that the identification
and weighing of quantifiable criteria (whether through
DCE or any other technique) should also be considered
as an integrated MCDA component.
The present application of MCDA seems especially use-
ful for policy planning in the long run as it can set priori-
ties among a large set of interventions without defining
the allocation of resources in a precise fashion. This use,
also labeled generalized priority setting, can have far-reach-
ing and constructive influences on policy formulation in
the long term [26]. In contrast, the use of MCDA as pre-
sented in this study may not be useful for guiding highly
contextualized decisions on the implementation of a single
intervention, since this requires a higher level of detail in
terms of financial and budgeting considerations.
This study has experimented with the inclusion of a
process of deliberation in MCDA in a research environ-
ment. As of now, Thailand is stepping towards a routine
application of MCDA to define its universal coverage
benefit package. Observations of that process reveal that
the inclusion of all relevant stakeholders right from the
beginning of the MCDA process is imperative to its suc-
cess [29].
Yet, we also observed a number of shortcomings in the
u s eo fM C D Ai nt h i ss t u d y .F i r s t ,D C Ea r ec o g n i t i v e
demanding and may not be appropriate for all stake-
holders. Most notably, PLWHA had difficulties in com-
pleting the DCE survey and interpreting the DCE
findings. Further research is needed on the use of less
cognitive demanding techniques than DCE that serve the
same goal [30]. Second, our intervention set was rela-
tively homogeneous in terms of the criteria covered in
the DCE (e.g. effectiveness; quality of evidence on effec-
tiveness; type of intervention), and this resulted in low
variation in the probabilities of inclusion. The application
of DCE across different health conditions [15-19] is, in
that respect, more powerful. Third, we did not engage all
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consensus on the rank ordering of interventions, an
adaption which would represent the final stage of a suc-
cessful priority setting process. However, the findings in
this study can serve as a reflection of other stakeholders’
preferences for policy decision making that may lead to
greater acceptance of priority setting decisions. More-
over, this study can be considered a lesson learned pro-
cess for other stakeholders, especially the general
population who have never been involved in health policy
decision-making, and can help them to understand how
to set priorities for health interventions. In future priority
setting research, it would there f o r eb ev a l u a b l et oi n c o r -
porate these public perspectives.
Although the set of criteria for MCDA may vary by
country and health system context, the approach is gen-
eralizable to other settings. Furthermore, the MCDA cri-
teria may be different if priority setting is required
across different health problems e.g. infectious diseases,
cardiovascular conditions, and mental health problems.
Therefore, further exploration is warranted.
Conclusion
This study has documented the feasibility of MCDA for
prioritising HIV/AIDS interventions in Thailand, and
has shown the usefulness of a deliberative process as an
integrated component of MCDA. MCDA holds potential
to contribute to a more transparent and accountable
priority setting process, and further application of this
approach in the prioritisation of health interventions is
warranted.
Additional material
Additional file 1: Appendix 1. The performance matrix of HIV/AIDS
interventions. Appendix 2. Discrete choice model results by perspective.
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